Nature — Melinda Wenner Moyer — August 25, 2015
“The growing global battle against blood-sucking ticks”
Borrelia burgdorferi infects an estimated 329,000 people in the United States each year, according to the US Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia.
Chicago Tribune — Leslie Mann — August 4, 2015
“Lyme disease still stuck in controversy, but there is hope”
“We want to kill Borrelia before it reaches humans,” said Mason Kauffman, CEO of Memphis-based US BIOLOGIC. In field trials, its rodent bait reduced Lyme-carrying ticks by 76 percent. After rodents eat the bait, their bodies create Lyme antibodies. When ticks bite these host rodents, the antibodies kill Borrelia in the tick.
Heat & Control Application Stories — August 2015
“US BIOLOGIC targets mice with vaccine-coated snacks to prevent transmission of Lyme disease”
The threat of zoonotic diseases can turn the most avid outdoor enthusiast into a couch potato.
The Tennessean — Jamie McGee — November 20, 2014
“Challenge Winner US Biologic Fights Lyme Disease”
The Cumberland Center, which seeks to invest in businesses and social enterprises making a difference in food and health, began its first investment last year with US Biologic, a company fighting Lyme disease.
From the 2014 Global Action Summit — Mason Kauffman
“Stopping Disease in Its Tracks: A New Approach to Address Zoonotic Diseases”
In November 2013, US BIOLOGIC was recognized at the Global South Summit as the top company in the Global Food Health Innovation Challenge.
Memphis Business Quarterly — Katherine Barnett — October 2014
“The 2014 Innovation Awards: Dr. Maria Gomes-Selecki of UTHSC”
“That’s the novelty of my approach,” says Gomes-Solecki. “I decided to take this back to nature and to vaccinate animals in the wild, to then make sure that the bacteria which causes Lyme disease wouldn’t get to people.”
PaxVax — September 3, 2014
“VaccineNation Names PaxVax CTO Dr. Thomas Monath #2 Most Influential Person in Vaccines”
“Tom is a pioneer in the development of vaccines against deadly diseases such as dengue and West Nile. His contributions have been invaluable as we’ve built out the industry’s most robust pipeline of specialty vaccine candidates for the compelling travel vaccine market.” — Kenneth Kelley, Chief Executive Officer of PaxVax
Memphis Business Journal — Michael Sheffield — March 20, 2014
“U.S. Biologic moving forward with Lyme disease prevention product”
Memphis-based U.S. Biologic is looking to rabies prevention as inspiration for the launch of its first product.
New Scientist — Alyssa Botelho — March 5, 2014
“Mouse vaccine could protect humans from Lyme disease”
Our newest weapon against Lyme disease might be a vaccine – for mice.
Reuters Health — Gabriel Miller — March 3, 2014
“Vaccine-laced mice bait lowers rate of Lyme disease bacteria in ticks”
Vaccinating mice can lower the proportion of ticks carrying the bacteria responsible for Lyme disease, according to a new study.
Huffington Post — C.M. Rubin — February 25, 2014
“The Global Search For Education: Ticks – Breaking the Transmission Cycle of Lyme Disease”
What if we could vaccinate the white-footed mice that account for the majority of the transmission of Borrelia burgdorferi (the cause of Lyme disease) and significantly reduce the level of tick infection?
Vaccine News Daily — Bryan Cohen — February 14, 2014
“New technology may prevent Lyme disease transmission”
Researchers developed a new technology that may reduce the level of tick infection of Borrelia burgdorferi, the cause of Lyme disease, according to a study published on Wednesday in the Journal of Infectious Diseases.
NBC News — Maggie Fox — February 12, 2014
“Lyme Vaccine for Mice Could Protect People”
An experimental vaccine to control Lyme disease by targeting the mice that spread it cut the number of infected ticks by more than 75 percent after a couple of years, researchers reported Wednesday.
Memphis Flyer — Bianca Phillips — December 5, 2013
“Ounce of Prevention”
Lyme disease sickens about 300,000 people per year, according to an August report from the Centers for Disease Control and Prevention, despite the fact that only 30,000 or so of those cases are reported annually.
But Memphis-based US Biologic and University of Tennessee Health Science Center professor Maria Gomes-Solecki are working on vaccination pellets for mice that would prevent the disease from spreading to humans.
Tennessee Representative Steve Cohen Recognizes US BIOLOGIC — December 2, 2013
Mr. Speaker, today I would like to recognize the work of Memphis-based U.S. Biologic in their work to halt the spread of Lyme disease. U.S. Biologic was recently awarded a grant of $1 million from the Global Food and Health Innovation Challenge to expand their research on this important topic and I am proud to honor the hard work of their dedicated research team, especially Maria Gomes-Solecki.
Nashville Business Journal — Staff — November 15, 2013
“Memphis company wins $1M innovation challenge”
Memphis-based company US Biologic won the $1 million Global Food and Health Innovation Challenge prize at the Global South Summit in Nashville this week for the development of a new product to prevent Lyme disease.